Àν¶¸° Ä¡·á ÁßÀÎ Á¦2Çü ´ç´¢º´È¯ÀÚÀÇ Ç÷´çÁ¶Àý¿¡ ´ç´¢º´ ÈÞ´ëÆùÀÌ ¹ÌÄ¡´Â È¿°ú
The Effect of Cellular Phone-Based Telemedicine on Glycemic Control in Type 2 Diabetes Patients Using Insulin Therapy

Korean Diabetes Journal 2009³â 33±Ç 3È£ p.232 ~ p.240

ÀÌÀ±Á¤(Lee Yun-Jeong) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Ãְ湬(Choi Kyung-Mook) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹é¼¼Çö(Baik Sei-Hyun) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
ÃÖµ¿¼·(Choi Dong-Seop) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
Á¤¹ÌÇö(Jeong Mi-Hyun) - °í·Á´ëÇб³ ¾È¾Ïº´¿ø ´ç´¢º´¼¾ÅÍ
±èÁÖÇü(Kim Ju-Hyung) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¹ÚÁÖ¸®(Park Ju-Ri) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±èÈñ¿µ(Kim Hee-Young) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
¼­Áö¾Æ(Seo Ji-A) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±è½Å°ï(Kim Sin-Gon) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç
±è³­Èñ(Kim Nan-Hee) - °í·Á´ëÇб³ ÀÇ°ú´ëÇÐ ³»°úÇб³½Ç

Abstract

¿¬±¸¹è°æ: ÈÞ´ëÆùÀº Çö´ë»çȸ¿¡¼­ ÀÇ»ç¼ÒÅë¿¡ Áß¿äÇÑ µµ ±¸·Î ÀÚ¸® Àâ¾Ò°í À̸¦ ÀÌ¿ëÇÑ ´ç´¢º´ ÈÞ´ëÆùÀº Ç÷´ç »óÅ ¿¡ ´ëÇÑ ½Ç½Ã°£ ¸ð´ÏÅ͸µ°ú ¹®ÀÚ ¸Þ½ÃÁö¸¦ ÅëÇÑ ÀûÀýÇÑ ÇÇ µå¹é(feedback)À» °¡´ÉÄÉ ÇÏ¿´´Ù. ±×·¯³ª Á¦2Çü ´ç´¢º´È¯ÀÚ ¿¡°Ô ´ç´¢º´ ÈÞ´ëÆùÀÌ ±âÁ¸ÀÇ ÀÚ°¡Ç÷´ç ÃøÁ¤¿¡ ºñÇØ Ç÷´çÁ¶ Àý¿¡ ´õ È¿°úÀûÀÎÁö¿¡ ´ëÇÑ ¿¬±¸´Â ¸¹Áö ¾Ê´Ù. ÀÌ¿¡ ÀúÀÚµé Àº Àν¶¸° Åõ¿©¿¡µµ ºÒ±¸ÇÏ°í Ç÷´çÁ¶ÀýÀÌ ¾çÈ£ÇÏÁö ¾ÊÀº Á¦ 2Çü ´ç´¢º´È¯ÀÚµéÀÇ Ç÷´çÁ¶Àý¿¡ ´ç´¢º´ ÈÞ´ëÆù »ç¿ëÀÌ ¹ÌÄ¡ ´Â È¿°ú¸¦ ¾Ë¾Æº¸°íÀÚ º» ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù.

¹æ¹ý: Àν¶¸°À¸·Î Ä¡·á ÁßÀ̸鼭 Ç÷´çÁ¶ÀýÀÌ ºÒ·®ÇÑ (HbA1c > 7%) Á¦2Çü ´ç´¢º´È¯ÀÚ ÃÑ 74¸íÀ» ´ë»óÀ¸·Î ¿¬±¸ ¸¦ ÁøÇàÇÏ¿´À¸¸ç ´ç´¢º´ ÈÞ´ëÆùÀ» »ç¿ëÇÑ ±º°ú ÀÚ°¡Ç÷´ç Ãø Á¤ ±ºÀ¸·Î ³ª´©¾î ¹«ÀÛÀ§ ¹èÁ¤ÇÏ¿´´Ù. ½ÃÇ豺ÀÇ Ç÷´çÀº ´ç ´¢º´ ÈÞ´ëÆùÀ» ÅëÇØ ¿Â¶óÀÎ µ¥ÀÌÅÍ·Î Àü¼ÛµÇ¾ú°í ÀÌ´Â ´ç´¢ Àü¹® °£È£»ç¸¦ ÅëÇØ °ËÅä µÇ¾îÁø ÈÄ ¹®ÀÚ ¸Þ½ÃÁö ÇüÅ·Πȯ Àڵ鿡°Ô Àü´ÞµÇ¾ú´Ù. 3°³¿ù ÈÄ ´çÈ­Ç÷»ö¼ÒÄ¡ ¹× ±âŸ ´Ù¸¥ °Ë»çÇ׸ñ¿¡ ´ëÇÑ °á°ú¸¦ ºñ±³ÇÏ¿´´Ù.

°á°ú: 3°³¿ù ÈÄ ´çÈ­Ç÷»ö¼Ò´Â ¾ç ±º ¸ðµÎ °¨¼ÒÇÏ¿´À¸³ª ´ëÁ¶±º(8.37%¿¡¼­ 8.20%·Î 0.20% °¨¼Ò, P = 0.152)º¸´Ù ½ÃÇ豺¿¡¼­ ´õ ¸¹ÀÌ °¨¼ÒÇÏ¿´´Ù(8.77%¿¡¼­ 8.16%·Î 0.61% °¨¼Ò, P < 0.001). ½ÃÇ豺 Áß ±âÀú ´çÈ­Ç÷»ö¼Ò °ªÀÌ 8% ¹Ì ¸¸ÀÎ ±º¿¡¼­´Â ¿¬±¸ Àü ÈÄ ´çÈ­Ç÷»ö¼Ò °ª¿¡ º¯È­°¡ ¾ø¾úÀ¸ ³ª, 8% ÀÌ»óÀÎ ±º¿¡¼­´Â ÀǹÌÀÖ°Ô °¨¼ÒÇÏ¿´´Ù(9.16%¿¡¼­ 8.34%·Î 0.81% °¨¼Ò, P < 0.001).

°á·Ð: ¿¬±¸ Á¾·á½ÃÁ¡¿¡¼­ ´ç´¢º´ ÈÞ´ëÆùÀ» »ç¿ëÇÑ ±ºÀÇ ´çÈ­Ç÷»ö¼Ò °ªÀÌ ÀÚ°¡Ç÷´ç ÃøÁ¤¸¸À» ½ÃÇàÇÑ ±º¿¡ ºñÇØ À¯ÀÇ ÇÏ°Ô Å« ÆøÀÇ °¨¼Ò¸¦ º¸¿´´Ù. ´ç´¢º´ ÈÞ´ëÆù »ç¿ëÀº Àν¶¸° À» Åõ¿©Çϸ鼭 ´ç Á¶Àý »óÅ°¡ ÁÁÁö ¾ÊÀº Á¦2Çü ´ç´¢º´È¯ÀÚ ÀÇ ´õ ³ªÀº Ç÷´çÁ¶Àý¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î Á¦¾ÈÇÏ´Â ¹ÙÀÌ´Ù.
Background: Cellular phones are extremely prevalent in modern society and they enable appropriate feedback mechanisms through real time monitoring and short message services regarding blood glucose levels. We investigated whether cellular phone-based telemedicine support system could improve blood glucose control in type 2 diabetes patients who were in inadequate glycemic control regardless of insulin therapy.

Methods: A randomized, controlled clinical trial was conducted involving 74 type 2 diabetic patients with suboptimal glycemic control (HbA1c levels > 7%) regardless of insulin therapy. The intervention (cellular phone-based telemedicine) group managed their blood glucose using a cellular phone for 3 months, while the control (self monitoring of blood glucose) group managed their blood glucose with a standard glucometer for the same period.

Results: Three months later, HbA1c levels were decreased in both groups. However, the decrease in the control group from 8.37% to 8.20% was only 0.20% (P = 0.152) which was not significant. In contrast, the intervention group had a significant reduction of 0.61% from 8.77% to 8.16% (P < 0.001). Moreover, among patients with a baseline ¡Ã 8%, the patients in the intervention group showed a significant reduction of 0.81% from 9.16% to 8.34% (P < 0.001).

Conclusion: HbA1c levels were significantly decreased in the cellular phone-based telemedicine group compared with the control group after 3 months. This study suggests that cellular phone-based telemedicine is helpful for better glucose control in type 2 diabetes patients who previously were unable to control glucose levels adequately with insulin therapy. (Korean Diabetes J 33:232-240, 2009)

Å°¿öµå

Cellular phone, Diabetes mellitus, Telemedicine
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø 
ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
HbA1c levels were significantly decreased in the cellular phone-based telemedicine group compared with the control group.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå